- Home
- SVA vs MIR Comparison
SVA vs MIR Comparison
Compare SVA & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVA
- MIR
- Stock Information
- Founded
- SVA N/A
- MIR 2005
- Country
- SVA
- MIR United States
- Employees
- SVA 3261
- MIR N/A
- Industry
- SVA
- MIR Industrial Machinery/Components
- Sector
- SVA
- MIR Technology
- Exchange
- SVA NYSE
- MIR Nasdaq
- Market Cap
- SVA N/A
- MIR 2.9B
- IPO Year
- SVA N/A
- MIR N/A
- Fundamental
- Price
- SVA $6.47
- MIR $14.04
- Analyst Decision
- SVA
- MIR Strong Buy
- Analyst Count
- SVA 0
- MIR 2
- Target Price
- SVA N/A
- MIR $14.00
- AVG Volume (30 Days)
- SVA N/A
- MIR 2.6M
- Earning Date
- SVA N/A
- MIR 10-29-2024
- Dividend Yield
- SVA N/A
- MIR N/A
- EPS Growth
- SVA N/A
- MIR N/A
- EPS
- SVA N/A
- MIR N/A
- Revenue
- SVA N/A
- MIR $821,300,000.00
- Revenue This Year
- SVA N/A
- MIR $7.10
- Revenue Next Year
- SVA N/A
- MIR $5.63
- P/E Ratio
- SVA N/A
- MIR N/A
- Revenue Growth
- SVA N/A
- MIR 8.34
- 52 Week Low
- SVA N/A
- MIR $6.70
- 52 Week High
- SVA N/A
- MIR $14.80
- Technical
- Relative Strength Index (RSI)
- SVA N/A
- MIR 71.80
- Support Level
- SVA N/A
- MIR $10.92
- Resistance Level
- SVA N/A
- MIR $14.71
- Average True Range (ATR)
- SVA 0.00
- MIR 0.58
- MACD
- SVA 0.00
- MIR 0.17
- Stochastic Oscillator
- SVA 0.00
- MIR 80.91
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allows customers to safely leverage the power of ionizing radiation for the greater good of humanity through critical applications in the medical, nuclear, defense markets, as well as laboratories, scientific research, analysis and exploration. The Company manages its operations through two segments: Medical and Technologies. The Medical segment provides radiation oncology quality assurance, delivering patient safety solutions for diagnostic imaging and radiation therapy centers. The Technologies segment is based around the nuclear energy, defense, laboratories, and scientific research markets as well as other industrial markets. It derives maximum revenue from Technologies Segment.